A comparison of HIMSS Analytics data from September 2011 to December 2011 suggests that a number of hospital segments showed increased capability to achieve Stage 1 of meaningful use.

February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with resistant hypertension (HTN), a major risk factor for cardiovascular disease.

February 20, 2012 —Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug-eluting stent (DES) for the treatment of coronary artery disease (CAD).

February 20, 2012 — U.S. Senate and House legislators have reached a “doc fix” agreement this week to prevent slashing payments to physicians treating Medicare patients. A law was to take effect at the beginning of March would have reduced reimbursements by 27 percent.

February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now